General Stability | Organism |
---|---|
activity in crude enzyme preparation is stable to repeated freezing and thawing | Providencia sp. |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Providencia sp. | - |
clinical isolate | - |
Providencia sp. 164 | - |
clinical isolate | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
acetyl-CoA + butirosin | acetylated at 30% the rate of gentamicin C1 | Providencia sp. | CoA + ? | - |
? | |
acetyl-CoA + dideoxykanamycin | acetylated at 92% the rate of gentamicin C1 | Providencia sp. | CoA + N2'-diacetyldideoxykanamycin | - |
? | |
acetyl-CoA + gentamicin B | 7% of the activity with gentamicin C1 | Providencia sp. | CoA + N2'-acetylgentamycin | - |
? | |
acetyl-CoA + gentamicin C1 | best substrate | Providencia sp. | CoA + N2'-acetylgentamicin C1 | - |
? | |
acetyl-CoA + gentamicin C1 | best substrate | Providencia sp. 164 | CoA + N2'-acetylgentamicin C1 | - |
? | |
acetyl-CoA + gentamicin C1a | acetylated at 86% the rate of gentamicin C1 | Providencia sp. | CoA + N2'-acetylgentamicin C1a | - |
? | |
acetyl-CoA + gentamicin C1a | acetylated at 86% the rate of gentamicin C1 | Providencia sp. 164 | CoA + N2'-acetylgentamicin C1a | - |
? | |
acetyl-CoA + kanamycin B | acetylated at 14% the rate of gentamicin C1 | Providencia sp. | CoA + N2-acetylkanamycin B | - |
? | |
acetyl-CoA + kanamycin C | acetylated at 40% the rate of gentamicin C1 | Providencia sp. | CoA + N2'-acetylkanamycin C | - |
? | |
acetyl-CoA + neomycin B | acetylated at 10% the rate of gentamicin C1 | Providencia sp. | CoA + N2'-acetylneomycin B | - |
? | |
acetyl-CoA + ribostamycin | acetylated at 15% the rate of gentamicin C1 | Providencia sp. | CoA + N2'-acetylribostamycin | - |
? | |
acetyl-CoA + sisomicin | acetylated at 71% the rate of gentamicin C1 | Providencia sp. | CoA + N3'-acetylsisomicin | - |
? | |
acetyl-CoA + sisomicin | acetylated at 71% the rate of gentamicin C1 | Providencia sp. 164 | CoA + N3'-acetylsisomicin | - |
? | |
acetyl-CoA + tobramycin | acetylated at 58% the rate of gentamicin C1 | Providencia sp. | CoA + N2'-acetyltobramycin | - |
? | |
acetyl-CoA + tobramycin | acetylated at 58% the rate of gentamicin C1 | Providencia sp. 164 | CoA + N2'-acetyltobramycin | - |
? | |
acetyl-CoA of soluble fragments of peptidoglycan + tobramycin | acetylated at 58% the rate of gentamicin C1 | Providencia sp. | ? | - |
? | |
additional information | no substrates are kanamycin A and 1-hydroxyaminobutyric acid kanamycin A-derivative BB-K 8 | Providencia sp. | ? | - |
? | |
additional information | no substrates are kanamycin A and 1-hydroxyaminobutyric acid kanamycin A-derivative BB-K 8 | Providencia sp. 164 | ? | - |
? | |
N-acetyl-D-glucosamine + tobramycin | acetylated at 58% the rate of gentamicin C1 | Providencia sp. | D-glucosamine + N2'-acetyltobramycin | - |
? |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
6 | - |
kanamycin C | Providencia sp. |
6.6 | - |
gentamicin C | Providencia sp. |
pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|
5.7 | 6.5 | about half-maximal activity at pH 5.7 and 6.5, kanamycin C | Providencia sp. |
6.4 | 7.6 | about half-maximal activity at pH 6.4 and 7.6, gentamicin C | Providencia sp. |